Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
This report aims to provide a comprehensive presentation of the global market for Gastric Motility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Drugs. This report contains market size and forecasts of Gastric Motility Drugs in global, including the following market information:
Global Gastric Motility Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Gastric Motility Drugs Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Gastric Motility Drugs companies in 2022 (%)
The global Gastric Motility Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastric Motility Drugs include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastric Motility Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Motility Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Poly Pill
Global Gastric Motility Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, by Application, 2022 (%)
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
Global Gastric Motility Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Motility Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastric Motility Drugs revenues share in global market, 2022 (%)
Key companies Gastric Motility Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastric Motility Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Motility Drugs, market overview.
Chapter 2: Global Gastric Motility Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Motility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Motility Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastric Motility Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Motility Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Motility Drugs Overall Market Size
2.1 Global Gastric Motility Drugs Market Size: 2022 VS 2032
2.2 Global Gastric Motility Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Gastric Motility Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Gastric Motility Drugs Players in Global Market
3.2 Top Global Gastric Motility Drugs Companies Ranked by Revenue
3.3 Global Gastric Motility Drugs Revenue by Companies
3.4 Global Gastric Motility Drugs Sales by Companies
3.5 Global Gastric Motility Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastric Motility Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastric Motility Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Motility Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastric Motility Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Motility Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastric Motility Drugs Market Size Markets, 2022 & 2032
4.1.2 Monotherapy
4.1.3 Poly Pill
4.2 By Type - Global Gastric Motility Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastric Motility Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gastric Motility Drugs Revenue, 2024-2032
4.2.3 By Type - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Gastric Motility Drugs Sales & Forecasts
4.3.1 By Type - Global Gastric Motility Drugs Sales, 2018-2023
4.3.2 By Type - Global Gastric Motility Drugs Sales, 2024-2032
4.3.3 By Type - Global Gastric Motility Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Gastric Motility Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastric Motility Drugs Market Size, 2022 & 2032
5.1.2 Chronic Gastritis
5.1.3 Reflux Esophagitis
5.1.4 Functional Dyspepsia
5.1.5 Others
5.2 By Application - Global Gastric Motility Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastric Motility Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gastric Motility Drugs Revenue, 2024-2032
5.2.3 By Application - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Gastric Motility Drugs Sales & Forecasts
5.3.1 By Application - Global Gastric Motility Drugs Sales, 2018-2023
5.3.2 By Application - Global Gastric Motility Drugs Sales, 2024-2032
5.3.3 By Application - Global Gastric Motility Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Gastric Motility Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Gastric Motility Drugs Market Size, 2022 & 2032
6.2 By Region - Global Gastric Motility Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastric Motility Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gastric Motility Drugs Revenue, 2024-2032
6.2.3 By Region - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Gastric Motility Drugs Sales & Forecasts
6.3.1 By Region - Global Gastric Motility Drugs Sales, 2018-2023
6.3.2 By Region - Global Gastric Motility Drugs Sales, 2024-2032
6.3.3 By Region - Global Gastric Motility Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Gastric Motility Drugs Revenue, 2018-2032
6.4.2 By Country - North America Gastric Motility Drugs Sales, 2018-2032
6.4.3 US Gastric Motility Drugs Market Size, 2018-2032
6.4.4 Canada Gastric Motility Drugs Market Size, 2018-2032
6.4.5 Mexico Gastric Motility Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Gastric Motility Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Gastric Motility Drugs Sales, 2018-2032
6.5.3 Germany Gastric Motility Drugs Market Size, 2018-2032
6.5.4 France Gastric Motility Drugs Market Size, 2018-2032
6.5.5 U.K. Gastric Motility Drugs Market Size, 2018-2032
6.5.6 Italy Gastric Motility Drugs Market Size, 2018-2032
6.5.7 Russia Gastric Motility Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Gastric Motility Drugs Market Size, 2018-2032
6.5.9 Benelux Gastric Motility Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Gastric Motility Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Gastric Motility Drugs Sales, 2018-2032
6.6.3 China Gastric Motility Drugs Market Size, 2018-2032
6.6.4 Japan Gastric Motility Drugs Market Size, 2018-2032
6.6.5 South Korea Gastric Motility Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Gastric Motility Drugs Market Size, 2018-2032
6.6.7 India Gastric Motility Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Gastric Motility Drugs Revenue, 2018-2032
6.7.2 By Country - South America Gastric Motility Drugs Sales, 2018-2032
6.7.3 Brazil Gastric Motility Drugs Market Size, 2018-2032
6.7.4 Argentina Gastric Motility Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastric Motility Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Gastric Motility Drugs Sales, 2018-2032
6.8.3 Turkey Gastric Motility Drugs Market Size, 2018-2032
6.8.4 Israel Gastric Motility Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Gastric Motility Drugs Market Size, 2018-2032
6.8.6 UAE Gastric Motility Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Gastric Motility Drugs Major Product Offerings
7.1.4 Johnson & Johnson Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Sumitomo Dainippon
7.2.1 Sumitomo Dainippon Company Summary
7.2.2 Sumitomo Dainippon Business Overview
7.2.3 Sumitomo Dainippon Gastric Motility Drugs Major Product Offerings
7.2.4 Sumitomo Dainippon Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sumitomo Dainippon Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Gastric Motility Drugs Major Product Offerings
7.3.4 Sanofi Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Gastric Motility Drugs Major Product Offerings
7.4.4 Pfizer Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Gastric Motility Drugs Major Product Offerings
7.5.4 Teva Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 GrupoFarma
7.6.1 GrupoFarma Company Summary
7.6.2 GrupoFarma Business Overview
7.6.3 GrupoFarma Gastric Motility Drugs Major Product Offerings
7.6.4 GrupoFarma Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GrupoFarma Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Gastric Motility Drugs Major Product Offerings
7.7.4 Abbott Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Kyowa Kirin
7.8.1 Kyowa Kirin Company Summary
7.8.2 Kyowa Kirin Business Overview
7.8.3 Kyowa Kirin Gastric Motility Drugs Major Product Offerings
7.8.4 Kyowa Kirin Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Kyowa Kirin Key News & Latest Developments
7.9 Sigma-Tau Group
7.9.1 Sigma-Tau Group Company Summary
7.9.2 Sigma-Tau Group Business Overview
7.9.3 Sigma-Tau Group Gastric Motility Drugs Major Product Offerings
7.9.4 Sigma-Tau Group Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sigma-Tau Group Key News & Latest Developments
7.10 Wilmington
7.10.1 Wilmington Company Summary
7.10.2 Wilmington Business Overview
7.10.3 Wilmington Gastric Motility Drugs Major Product Offerings
7.10.4 Wilmington Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Wilmington Key News & Latest Developments
7.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd
7.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Summary
7.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Business Overview
7.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Major Product Offerings
7.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Key News & Latest Developments
7.12 Lunan Pharmaceutical Group Corporation
7.12.1 Lunan Pharmaceutical Group Corporation Company Summary
7.12.2 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Business Overview
7.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Major Product Offerings
7.12.4 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Lunan Pharmaceutical Group Corporation Key News & Latest Developments
7.13 Hansoh Pharmaceutical Group Company Limited
7.13.1 Hansoh Pharmaceutical Group Company Limited Company Summary
7.13.2 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Business Overview
7.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Major Product Offerings
7.13.4 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Hansoh Pharmaceutical Group Company Limited Key News & Latest Developments
7.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd
7.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Summary
7.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Business Overview
7.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Major Product Offerings
7.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Key News & Latest Developments
7.15 Disha Pharmaceutical Group Co., Ltd
7.15.1 Disha Pharmaceutical Group Co., Ltd Company Summary
7.15.2 Disha Pharmaceutical Group Co., Ltd Business Overview
7.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Major Product Offerings
7.15.4 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Disha Pharmaceutical Group Co., Ltd Key News & Latest Developments
7.16 Xian Janssen Pharmaceutical Ltd
7.16.1 Xian Janssen Pharmaceutical Ltd Company Summary
7.16.2 Xian Janssen Pharmaceutical Ltd Business Overview
7.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Major Product Offerings
7.16.4 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Xian Janssen Pharmaceutical Ltd Key News & Latest Developments
8 Global Gastric Motility Drugs Production Capacity, Analysis
8.1 Global Gastric Motility Drugs Production Capacity, 2018-2032
8.2 Gastric Motility Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Motility Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Motility Drugs Supply Chain Analysis
10.1 Gastric Motility Drugs Industry Value Chain
10.2 Gastric Motility Drugs Upstream Market
10.3 Gastric Motility Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Motility Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastric Motility Drugs in Global Market
Table 2. Top Gastric Motility Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastric Motility Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastric Motility Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gastric Motility Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Gastric Motility Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastric Motility Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gastric Motility Drugs Product Type
Table 9. List of Global Tier 1 Gastric Motility Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastric Motility Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Gastric Motility Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastric Motility Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Gastric Motility Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Gastric Motility Drugs Sales (K Units), 2024-2032
Table 16. By Application ? Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Gastric Motility Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastric Motility Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Gastric Motility Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Gastric Motility Drugs Sales (K Units), 2024-2032
Table 21. By Region ? Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Gastric Motility Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastric Motility Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Gastric Motility Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Gastric Motility Drugs Sales (K Units), 2024-2032
Table 26. By Country - North America Gastric Motility Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastric Motility Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Gastric Motility Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Gastric Motility Drugs Sales, (K Units), 2024-2032
Table 30. By Country - Europe Gastric Motility Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastric Motility Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Gastric Motility Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gastric Motility Drugs Sales, (K Units), 2024-2032
Table 34. By Region - Asia Gastric Motility Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastric Motility Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Gastric Motility Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gastric Motility Drugs Sales, (K Units), 2024-2032
Table 38. By Country - South America Gastric Motility Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastric Motility Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Gastric Motility Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Gastric Motility Drugs Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Gastric Motility Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastric Motility Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Gastric Motility Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gastric Motility Drugs Sales, (K Units), 2024-2032
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Gastric Motility Drugs Product Offerings
Table 48. Johnson & Johnson Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Sumitomo Dainippon Company Summary
Table 51. Sumitomo Dainippon Gastric Motility Drugs Product Offerings
Table 52. Sumitomo Dainippon Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sumitomo Dainippon Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Gastric Motility Drugs Product Offerings
Table 56. Sanofi Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Gastric Motility Drugs Product Offerings
Table 60. Pfizer Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Gastric Motility Drugs Product Offerings
Table 64. Teva Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. GrupoFarma Company Summary
Table 67. GrupoFarma Gastric Motility Drugs Product Offerings
Table 68. GrupoFarma Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. GrupoFarma Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Gastric Motility Drugs Product Offerings
Table 72. Abbott Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Abbott Key News & Latest Developments
Table 74. Kyowa Kirin Company Summary
Table 75. Kyowa Kirin Gastric Motility Drugs Product Offerings
Table 76. Kyowa Kirin Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Kyowa Kirin Key News & Latest Developments
Table 78. Sigma-Tau Group Company Summary
Table 79. Sigma-Tau Group Gastric Motility Drugs Product Offerings
Table 80. Sigma-Tau Group Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Sigma-Tau Group Key News & Latest Developments
Table 82. Wilmington Company Summary
Table 83. Wilmington Gastric Motility Drugs Product Offerings
Table 84. Wilmington Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Wilmington Key News & Latest Developments
Table 86. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Summary
Table 87. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product Offerings
Table 88. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Key News & Latest Developments
Table 90. Lunan Pharmaceutical Group Corporation Company Summary
Table 91. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product Offerings
Table 92. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Lunan Pharmaceutical Group Corporation Key News & Latest Developments
Table 94. Hansoh Pharmaceutical Group Company Limited Company Summary
Table 95. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product Offerings
Table 96. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Hansoh Pharmaceutical Group Company Limited Key News & Latest Developments
Table 98. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Summary
Table 99. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product Offerings
Table 100. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Key News & Latest Developments
Table 102. Disha Pharmaceutical Group Co., Ltd Company Summary
Table 103. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product Offerings
Table 104. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Disha Pharmaceutical Group Co., Ltd Key News & Latest Developments
Table 106. Xian Janssen Pharmaceutical Ltd Company Summary
Table 107. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product Offerings
Table 108. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Xian Janssen Pharmaceutical Ltd Key News & Latest Developments
Table 110. Gastric Motility Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Gastric Motility Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Gastric Motility Drugs Production by Region, 2018-2023 (K Units)
Table 113. Global Gastric Motility Drugs Production by Region, 2024-2032 (K Units)
Table 114. Gastric Motility Drugs Market Opportunities & Trends in Global Market
Table 115. Gastric Motility Drugs Market Drivers in Global Market
Table 116. Gastric Motility Drugs Market Restraints in Global Market
Table 117. Gastric Motility Drugs Raw Materials
Table 118. Gastric Motility Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Gastric Motility Drugs Downstream
Table 120. Gastric Motility Drugs Downstream Clients in Global Market
Table 121. Gastric Motility Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastric Motility Drugs Segment by Type in 2022
Figure 2. Gastric Motility Drugs Segment by Application in 2022
Figure 3. Global Gastric Motility Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastric Motility Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Gastric Motility Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Gastric Motility Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastric Motility Drugs Revenue in 2022
Figure 9. By Type - Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Gastric Motility Drugs Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Gastric Motility Drugs Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Gastric Motility Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Gastric Motility Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 23. US Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 28. Germany Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 37. China Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Gastric Motility Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Gastric Motility Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Gastric Motility Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Gastric Motility Drugs Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Gastric Motility Drugs by Region, 2022 VS 2032
Figure 54. Gastric Motility Drugs Industry Value Chain
Figure 55. Marketing Channels
